Benjamin Avi Derman
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Oncology top 10%
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
Papers in
- Hematology 55
- Multiple Myeloma Research and Treatments 54
- Oncology 38
- CAR-T cell therapy research 17
- Cancer Treatment and Pharmacology 10
- Peptidase Inhibition and Analysis 8
- Co-authors
- Andrzej J. Jakubowiak (22 shared papers)Jagoda K. Jasielec (9 shared papers)Mary J. Fidler (2 shared papers)Marta Batus (2 shared papers)Philip Bonomi (2 shared papers)Andrzej J. Jakubowiak (9 shared papers)Kathryn Finch Mileham (1 shared paper)Tadeusz Kubicki (6 shared papers)
- Journals
- Blood Advances (7 papers)Blood Cancer Journal (7 papers)Blood (6 papers)Leukemia (4 papers)Journal of the National Comprehensive Cancer Network (3 papers)
- Partner nations
- United StatesPolandIndia
In The Last Decade
Benjamin Avi Derman
81 papers receiving 1.3k citations
Benjamin Avi Derman's Hit Papers
Peers
Comparison fields: 5 of 81
- Hematology 732
- Oncology 489
- Geriatrics and Gerontology 46
- Genetics 94
- Molecular Biology 413
Countries citing papers authored by Benjamin Avi Derman
This map shows the geographic impact of Benjamin Avi Derman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Avi Derman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Avi Derman more than expected).
Fields of papers citing papers by Benjamin Avi Derman
This network shows the impact of papers produced by Benjamin Avi Derman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Avi Derman. The network helps show where Benjamin Avi Derman may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Avi Derman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 99 | |
| 2 | International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma Hit paper breakdown → | 2024 | 84 |
| 3 | 2015 | 76 | |
| 4 | 2019 | 75 | |
| 5 | 2020 | 62 | |
| 6 | 2020 | 61 | |
| 7 | 2017 | 58 | |
| 8 | 2021 | 54 | |
| 9 | 2023 | 54 | |
| 10 | 2020 | 49 | |
| 11 | 2024 | 47 | |
| 12 | 2022 | 37 | |
| 13 | 2019 | 36 | |
| 14 | International myeloma working group immunotherapy committee recommendation on sequencing immunotherapy for treatment of multiple myeloma Hit paper breakdown → | 2025 | 35 |
| 15 | 2022 | 30 | |
| 16 | 2020 | 27 | |
| 17 | 2024 | 26 | |
| 18 | 2024 | 23 | |
| 19 | 2015 | 21 | |
| 20 | 2021 | 20 |
About Benjamin Avi Derman
Benjamin Avi Derman is a scholar working on Hematology, Oncology, Molecular Biology, Genetics and Immunology, having authored 89 papers that have together received 1.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (54 papers), Protein Degradation and Inhibitors (20 papers), CAR-T cell therapy research (17 papers), Cancer Treatment and Pharmacology (10 papers), Peptidase Inhibition and Analysis (8 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Acute Lymphoblastic Leukemia research (4 papers). The work is most often cited by research in Hematology (732 citations), Oncology (489 citations), Geriatrics and Gerontology (46 citations), Genetics (94 citations) and Molecular Biology (413 citations). Benjamin Avi Derman has collaborated with scholars based in United States, Poland and India. Frequent co-authors include Andrzej J. Jakubowiak, Jagoda K. Jasielec, Mary J. Fidler, Marta Batus, Philip Bonomi, Andrzej J. Jakubowiak, Kathryn Finch Mileham, Tadeusz Kubicki, Wei Zhang and Brian C.‐H. Chiu. Their work appears in journals such as Blood Advances, Blood Cancer Journal, Blood, Leukemia and Journal of the National Comprehensive Cancer Network.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.